Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

High-mobility group box-1 protein in adenine-induced chronic renal failure and the influence of gum arabic thereon

B. H. Ali, M. Al Za'abi, A. Al Shukaili, A. Nemmar,

. 2015 ; 64 (1) : 147-151. [pub] 20140905

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15040051

Pathogenesis of adenine-induced chronic renal failure may involve inflammatory, immunological and/or oxidant mechanisms. Gum arabic (GA) is a complex polysaccharide that acts as an anti-oxidant which can modulate inflammatory and/or immunological processes. Therefore, we tested here the effect of GA treatment (15 % in the drinking water for 4 weeks) in plasma and urine of rats, on a novel cytokine that has been shown to be pro-inflammatory, viz, DNA-binding high-mobility group box-1 protein (HMGB1). Adenine (0.75 % in the feed, 4 weeks) significantly increased indoxyl sulphate, urea and creatinine concentrations in plasma, and significantly decreased the creatinine clearance. GA significantly abated these effects. The concentrations of HMGB1 in urine before the start of the experiment were similar in all four groups. However, 24 h after the last treatment, adenine treatment increased significantly the concentration of HMGB1 when compared with the control. GA treatment did not affect the HMGB1 concentration in urine. Moreover, the concentration of HMGB1 in plasma obtained 24 h after the last treatment in rats treated with adenine was drastically reduced compared with the control group. This may explain its significant rise in urine. In conclusion, HMGB1 can be considered a potentially useful biomarker in adenine induced CRF and its treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15040051
003      
CZ-PrNML
005      
20200120153626.0
007      
ta
008      
151230s2015 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.932759 $2 doi
035    __
$a (PubMed)25194125
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Ali, B. H. $u Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Oman $7 gn_A_00004176
245    10
$a High-mobility group box-1 protein in adenine-induced chronic renal failure and the influence of gum arabic thereon / $c B. H. Ali, M. Al Za'abi, A. Al Shukaili, A. Nemmar,
520    9_
$a Pathogenesis of adenine-induced chronic renal failure may involve inflammatory, immunological and/or oxidant mechanisms. Gum arabic (GA) is a complex polysaccharide that acts as an anti-oxidant which can modulate inflammatory and/or immunological processes. Therefore, we tested here the effect of GA treatment (15 % in the drinking water for 4 weeks) in plasma and urine of rats, on a novel cytokine that has been shown to be pro-inflammatory, viz, DNA-binding high-mobility group box-1 protein (HMGB1). Adenine (0.75 % in the feed, 4 weeks) significantly increased indoxyl sulphate, urea and creatinine concentrations in plasma, and significantly decreased the creatinine clearance. GA significantly abated these effects. The concentrations of HMGB1 in urine before the start of the experiment were similar in all four groups. However, 24 h after the last treatment, adenine treatment increased significantly the concentration of HMGB1 when compared with the control. GA treatment did not affect the HMGB1 concentration in urine. Moreover, the concentration of HMGB1 in plasma obtained 24 h after the last treatment in rats treated with adenine was drastically reduced compared with the control group. This may explain its significant rise in urine. In conclusion, HMGB1 can be considered a potentially useful biomarker in adenine induced CRF and its treatment.
650    12
$a adenin $7 D000225
650    _2
$a zvířata $7 D000818
650    _2
$a biologické markery $x krev $x moč $7 D015415
650    _2
$a kreatinin $x krev $7 D003404
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a arabská guma $x farmakologie $7 D006170
650    _2
$a protein HMGB1 $x krev $x metabolismus $x moč $7 D024243
650    _2
$a indican $x krev $7 D007200
650    _2
$a mediátory zánětu $x krev $x metabolismus $x moč $7 D018836
650    _2
$a ledviny $x účinky léků $x metabolismus $x patofyziologie $7 D007668
650    _2
$a chronické selhání ledvin $x chemicky indukované $x farmakoterapie $x metabolismus $x patofyziologie $7 D007676
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a potkani Wistar $7 D017208
650    _2
$a časové faktory $7 D013997
650    _2
$a močovina $x krev $7 D014508
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Al Za'abi, M. $u Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Oman $7 gn_A_00003198
700    1_
$a Al Shukaili, A. $u Department of Microbiology, College of Medicine and Health Sciences, Sultan Qaboos University, Oman $7 gn_A_00003182
700    1_
$a Nemmar, A. $7 _AN077984 $u Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE
773    0_
$w MED00003824 $t Physiological research Academia Scientiarum Bohemoslovaca $x 1802-9973 $g Roč. 64, č. 1 (2015), s. 147-151
856    41
$u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20151230 $b ABA008
991    __
$a 20200120154003 $b ABA008
999    __
$a ok $b bmc $g 1103719 $s 923278
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 64 $c 1 $d 147-151 $e 20140905 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20151230

Najít záznam

Citační ukazatele

Možnosti archivace